Alternatively, an understanding of natural ICLs has allowed the development of molecular-targeted drugs, such as alda-1 (ALDH2 agonist) and metformin (aldehyde scavenger) [29, 30], for the prevention of cancer or BMF in patients with FA. The gene discussed is ALDH2; the disease is cancer.